Aurinia Pharmaceuticals Inc (AUP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 59,867 | 67,771 | 57,192 | 50,303 | 45,095 |
| Cost of Goods | 5,552 | 6,035 | 8,909 | 7,752 | 5,395 |
| Gross Profit | 54,315 | 61,736 | 48,283 | 42,551 | 39,700 |
| Operating Expenses | 40,633 | 49,988 | 48,724 | 49,121 | 69,374 |
| Operating Income | 13,682 | 11,748 | -441 | -6,570 | -29,674 |
| Interest Expense | 1,146 | 1,208 | 1,198 | 1,283 | 1,310 |
| Other Income | -11,363 | 4,267 | 3,117 | -2,157 | 4,568 |
| Pre-tax Income | 1,173 | 14,807 | 1,478 | -10,010 | -26,416 |
| Income Tax | -256 | 457 | 756 | 739 | 459 |
| Net Income Continuous | 1,429 | 14,350 | 722 | -10,749 | -26,875 |
| Net Income | $1,429 | $14,350 | $722 | $-10,749 | $-26,875 |
| EBITDA(a) | $7,181 | $20,908 | $7,519 | $-3,880 | $-20,157 |